"Infertility treatment amongst first drugs included on FDA’s new priority voucher scheme" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.

The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as ...

While a new facility setup program aimed at encouraging onshoring received a positive reception at a recent meeting, industry ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and Drug ...

The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...

Applicants can request this priority review by following the procedures outlined in FDA’s Manual of Policies and Procedures (MAPP) 5240.3, Prioritization of the Review of Original ANDAs, Amendments, ...

The FDA is experiencing rising delays in drug approvals, raising concerns about operational strain within the agency, according to an RBC Capital ...

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...